GE Healthcare Teams With SHINE To Develop Radioisotope – Minus Highly-Enriched Uranium

Read full post at Med Device Online. Today, SHINE and GE Healthcare announced they have successfully obtained pharmaceutical-grade Tc99m from GE Healthcare’s Drytec (Technetium Tc99m Generator) For the Production of Sodium Pertechnetate for Tc99m Injection, using Mo-99 produced by SHINE’s innovative process…

Posted in News | Comments closed
Read More »

NorthStar Medical Radioisotopes Receives $11.75 Million From National Nuclear Security Administration

Read full post at Market Wired.
NorthStar Medical Radioisotopes LLC has received $11.75 million from the U.S. Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) for continued development and commercialization of two technologies to produce the medical radioisotope molybdenum-99 (Mo-99) without the use of highly enriched uranium (HEU)…

Posted in News | Comments closed
Read More »

Nordion Partnership gets US Funding for New Isotope Process

Read full post at Ottawa Community News.
Medical isotope producer Nordion has struck a new partnership as it prepares to sever ties with Canada’s Chalk River nuclear reactor, as it closes after more than 50 years as a source of radioactive material…

Posted in News | Comments closed
Read More »

United Pharmacy Partners Proudly Announces That 31 Nuclear Pharmacy Members & Affiliates Received a Recognition Award from the U.S. Department of Energy

Read full posts at Businesswire.
United Pharmacy Partners is proud to announce that thirty-one (31) nuclear pharmacy members and affiliates have received a Recognition Award from the U.S. Department of Energy’s National Nuclear Security Administration in recognition of providing radiopharmaceuticals of molybdenum 99/technetium 99m derived from sources with low enriched uranium (LEU)…

Posted in News | Comments closed
Read More »

Significant Milestone Reached for Australia’s New Nuclear Medicine Manufacturing Plant

Read full post at Manufacturer’s Monthly.
Australia is a step closer to becoming a global, high end manufacturer of nuclear medicines, with construction well underway on a brand new, $168 million ANSTO Nuclear Medicine (ANM) facility…

Posted in News | Comments closed
Read More »